Placental caspase-3 expression in preeclampsia: a systematic review of observational evidence
Obstetrics & Gynecology Science · 15.11.2026 · 69 (6) · 391-403
DOI: 10.5468/ogs.25360 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.11.2026. Verfasst von Graciella Angelica Lukas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia. graciellangelica9@gmail.com. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Preeclampsia is a pregnancy disorder that contributes substantially to maternal and fetal morbidity and mortality worldwide. Apoptosis has been implicated in its pathogenesis, particularly in placental dysfunction. Caspase-3, an executioner caspase, mediates the final stage of apoptotic signaling; however, its role in preeclampsia remains incompletely defined. This systematic review evaluated observational evidence on placental caspase-3 expression in preeclampsia. PubMed, Scopus, and ScienceDirect were systematically searched on June 21, 2024. Eligible studies were human observational studies that assessed caspase-3 expression in placental tissue from pregnancies complicated by preeclampsia. Risk of bias was evaluated using the Newcastle-Ottawa Scale and the Risk of Bias Assessment Tool for Nonrandomized Studies 2.0 (RoBANS 2.0). Data were synthesized qualitatively because of substantial methodological heterogeneity. Twelve studies (n=736 pregnancies) were included. All assessed caspase-3 expression in placental tissue obtained after delivery. Most reported higher caspase-3 expression in preeclamptic placentas than in normotensive controls; two studies suggested higher expression in early-onset and severe preeclampsia. However, the studies varied substantially in diagnostic subtypes, measurement methods (including immunohistochemistry scoring systems, Western blotting, and enzyme-linked immunosorbent assay), and control of confounding variables. Observational evidence consistently indicates increased placental caspase-3 expression in preeclampsia, supporting enhanced apoptotic activity in affected placentas. However, because measurements were performed after delivery and caspase-3 is a downstream executioner caspase, current evidence supports its use as a marker of established placental injury. Further mechanistic and longitudinal studies are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia. graciellangelica9@gmail.com.
- Fetomaternal Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
- Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
Zitieren
APA
Lukas, G. A., Prabowo, W., Rahma, A. A., Suhartono, M. I., Fatahillah, H., Pradana, H. Y., Ilyas, M. F., & Wijayanto, M. A. (2026). Placental caspase-3 expression in preeclampsia: a systematic review of observational evidence. Obstetrics & Gynecology Science, 69(6), 391-403. https://doi.org/10.5468/ogs.25360
Vancouver
Lukas GA, Prabowo W, Rahma AA, Suhartono MI, Fatahillah H, Pradana HY, et al. Placental caspase-3 expression in preeclampsia: a systematic review of observational evidence. Obstetrics & Gynecology Science. 2026;69(6):391-403. doi:10.5468/ogs.25360
BibTeX
@article{Lukas2026,
author = {Lukas, Graciella Angelica and Prabowo, Wisnu and Rahma, Annisa Aghnia and Suhartono, Maurilla Iascha and Fatahillah, Hidayat and Pradana, Hikam Yanwar and Ilyas, Muhana Fawwazy and Wijayanto, Matthew Aldo},
title = {Placental caspase-3 expression in preeclampsia: a systematic review of observational evidence},
journal = {Obstetrics & Gynecology Science},
year = {2026},
volume = {69},
number = {6},
pages = {391--403},
doi = {10.5468/ogs.25360}
}
EUVIMED